Christian Sordo-Bahamonde

8PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 16, 2024
Hyperalgesic Effect Evoked by il-16 and its Participation in Inflammatory Hypernociception in Mice.

Sara González-Rodríguez, Christian Sordo-Bahamonde, Alejandro Álvarez-Artime

|Jun 10, 2023
Chemo-Immunotherapy: A New Trend in Cancer Treatment.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez

|Sep 09, 2022
Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma.

Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Alejandra Martínez-Pérez

|Apr 26, 2022
Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.

Francisco-Javier Cepeda-Piorno, Esther González-García, Alba Méndez-Gallego

|Apr 30, 2021
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P González-Rodríguez

|Apr 30, 2021
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez

Pageof 2